Cargando…

The value of serum progesterone level on day of human chorionic gonadotrophin administration / metaphase II oocyte ratio in predicting IVF/ICSI outcome in patients with normal ovarian reserve

BACKGROUND: The clinical implication of the increased serum progesterone level on the day of HCG administration in assisted reproduction treatment (ART) is still controversial. The current study aimed to compare the predictive value of serum progesterone on day of HCG administration / metaphase II o...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahran, Ahmad, Khairy, Mohammed, Elkhateeb, Reham, Hegazy, Abdel Rahman, Abdelmeged, Ayman, Batiha, Gaber El-Saber, Alsharif, Khalaf F., Hetta, Helal F., Bahaa, Haitham Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017661/
https://www.ncbi.nlm.nih.gov/pubmed/33794989
http://dx.doi.org/10.1186/s13048-021-00800-5
_version_ 1783674094337654784
author Mahran, Ahmad
Khairy, Mohammed
Elkhateeb, Reham
Hegazy, Abdel Rahman
Abdelmeged, Ayman
Batiha, Gaber El-Saber
Alsharif, Khalaf F.
Hetta, Helal F.
Bahaa, Haitham Ahmed
author_facet Mahran, Ahmad
Khairy, Mohammed
Elkhateeb, Reham
Hegazy, Abdel Rahman
Abdelmeged, Ayman
Batiha, Gaber El-Saber
Alsharif, Khalaf F.
Hetta, Helal F.
Bahaa, Haitham Ahmed
author_sort Mahran, Ahmad
collection PubMed
description BACKGROUND: The clinical implication of the increased serum progesterone level on the day of HCG administration in assisted reproduction treatment (ART) is still controversial. The current study aimed to compare the predictive value of serum progesterone on day of HCG administration / metaphase II oocyte (P/MII) ratio on IVF/ ICSI outcome to serum progesterone (P) level alone and the ratio of serum progesterone/estradiol level (P/E2) ratio in prediction of pregnancy rates after ART. MATERIAL & METHODS: Two hundred patients admitted to the IVF/ICSI program at Minia IVF center in Egypt in the period from October 2016 to May 2018 were included in this study. Serum Progesterone (P) and Estradiol (E2) levels were estimated on the day of HCG administration. The ratio between serum P and the number of MII oocytes (P/MII ratio) was calculated and the predictive values of the three parameters (P, P/E2 ratio and P/MII ratio) in prediction of cycle outcomes were measured. RESULTS: P/ MII oocyte ratio was significantly lower in patients who attained clinical pregnancy (n = 97) as compared with those who couldn’t whilst there was no significant difference in P and P/E2 ratio between the two groups. Using a cut off value of 0.125, the sensitivity and specificity of progesterone/ MII ratio in prediction of no pregnancy in IVF/ICSI were 75.7 and 77.1% respectively with the area under The Receiver operating curve (ROC-AUC) = 0.808. The respective values of the ROC-AUC for the P and P/E2 ratio were 0.651 and 0.712 with sensitivity and specificity of 71.2 and 73.5%for P level and of 72.5 and 75.3% for P/E2 ratio. Implantation or clinical pregnancy rates were significantly different between patients with high and low P/MII ratio irrespective of day of embryo transfer (day 3 or 5). CONCLUSIONS: In patients with normal ovarian response, serum progesterone on day of HCG / MII oocyte ratio can be a useful predictor of pregnancy outcomes and in deciding on freezing of all embryos for later transfer instead of high progesterone level alone.
format Online
Article
Text
id pubmed-8017661
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80176612021-04-02 The value of serum progesterone level on day of human chorionic gonadotrophin administration / metaphase II oocyte ratio in predicting IVF/ICSI outcome in patients with normal ovarian reserve Mahran, Ahmad Khairy, Mohammed Elkhateeb, Reham Hegazy, Abdel Rahman Abdelmeged, Ayman Batiha, Gaber El-Saber Alsharif, Khalaf F. Hetta, Helal F. Bahaa, Haitham Ahmed J Ovarian Res Research BACKGROUND: The clinical implication of the increased serum progesterone level on the day of HCG administration in assisted reproduction treatment (ART) is still controversial. The current study aimed to compare the predictive value of serum progesterone on day of HCG administration / metaphase II oocyte (P/MII) ratio on IVF/ ICSI outcome to serum progesterone (P) level alone and the ratio of serum progesterone/estradiol level (P/E2) ratio in prediction of pregnancy rates after ART. MATERIAL & METHODS: Two hundred patients admitted to the IVF/ICSI program at Minia IVF center in Egypt in the period from October 2016 to May 2018 were included in this study. Serum Progesterone (P) and Estradiol (E2) levels were estimated on the day of HCG administration. The ratio between serum P and the number of MII oocytes (P/MII ratio) was calculated and the predictive values of the three parameters (P, P/E2 ratio and P/MII ratio) in prediction of cycle outcomes were measured. RESULTS: P/ MII oocyte ratio was significantly lower in patients who attained clinical pregnancy (n = 97) as compared with those who couldn’t whilst there was no significant difference in P and P/E2 ratio between the two groups. Using a cut off value of 0.125, the sensitivity and specificity of progesterone/ MII ratio in prediction of no pregnancy in IVF/ICSI were 75.7 and 77.1% respectively with the area under The Receiver operating curve (ROC-AUC) = 0.808. The respective values of the ROC-AUC for the P and P/E2 ratio were 0.651 and 0.712 with sensitivity and specificity of 71.2 and 73.5%for P level and of 72.5 and 75.3% for P/E2 ratio. Implantation or clinical pregnancy rates were significantly different between patients with high and low P/MII ratio irrespective of day of embryo transfer (day 3 or 5). CONCLUSIONS: In patients with normal ovarian response, serum progesterone on day of HCG / MII oocyte ratio can be a useful predictor of pregnancy outcomes and in deciding on freezing of all embryos for later transfer instead of high progesterone level alone. BioMed Central 2021-04-01 /pmc/articles/PMC8017661/ /pubmed/33794989 http://dx.doi.org/10.1186/s13048-021-00800-5 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Mahran, Ahmad
Khairy, Mohammed
Elkhateeb, Reham
Hegazy, Abdel Rahman
Abdelmeged, Ayman
Batiha, Gaber El-Saber
Alsharif, Khalaf F.
Hetta, Helal F.
Bahaa, Haitham Ahmed
The value of serum progesterone level on day of human chorionic gonadotrophin administration / metaphase II oocyte ratio in predicting IVF/ICSI outcome in patients with normal ovarian reserve
title The value of serum progesterone level on day of human chorionic gonadotrophin administration / metaphase II oocyte ratio in predicting IVF/ICSI outcome in patients with normal ovarian reserve
title_full The value of serum progesterone level on day of human chorionic gonadotrophin administration / metaphase II oocyte ratio in predicting IVF/ICSI outcome in patients with normal ovarian reserve
title_fullStr The value of serum progesterone level on day of human chorionic gonadotrophin administration / metaphase II oocyte ratio in predicting IVF/ICSI outcome in patients with normal ovarian reserve
title_full_unstemmed The value of serum progesterone level on day of human chorionic gonadotrophin administration / metaphase II oocyte ratio in predicting IVF/ICSI outcome in patients with normal ovarian reserve
title_short The value of serum progesterone level on day of human chorionic gonadotrophin administration / metaphase II oocyte ratio in predicting IVF/ICSI outcome in patients with normal ovarian reserve
title_sort value of serum progesterone level on day of human chorionic gonadotrophin administration / metaphase ii oocyte ratio in predicting ivf/icsi outcome in patients with normal ovarian reserve
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017661/
https://www.ncbi.nlm.nih.gov/pubmed/33794989
http://dx.doi.org/10.1186/s13048-021-00800-5
work_keys_str_mv AT mahranahmad thevalueofserumprogesteronelevelondayofhumanchorionicgonadotrophinadministrationmetaphaseiioocyteratioinpredictingivficsioutcomeinpatientswithnormalovarianreserve
AT khairymohammed thevalueofserumprogesteronelevelondayofhumanchorionicgonadotrophinadministrationmetaphaseiioocyteratioinpredictingivficsioutcomeinpatientswithnormalovarianreserve
AT elkhateebreham thevalueofserumprogesteronelevelondayofhumanchorionicgonadotrophinadministrationmetaphaseiioocyteratioinpredictingivficsioutcomeinpatientswithnormalovarianreserve
AT hegazyabdelrahman thevalueofserumprogesteronelevelondayofhumanchorionicgonadotrophinadministrationmetaphaseiioocyteratioinpredictingivficsioutcomeinpatientswithnormalovarianreserve
AT abdelmegedayman thevalueofserumprogesteronelevelondayofhumanchorionicgonadotrophinadministrationmetaphaseiioocyteratioinpredictingivficsioutcomeinpatientswithnormalovarianreserve
AT batihagaberelsaber thevalueofserumprogesteronelevelondayofhumanchorionicgonadotrophinadministrationmetaphaseiioocyteratioinpredictingivficsioutcomeinpatientswithnormalovarianreserve
AT alsharifkhalaff thevalueofserumprogesteronelevelondayofhumanchorionicgonadotrophinadministrationmetaphaseiioocyteratioinpredictingivficsioutcomeinpatientswithnormalovarianreserve
AT hettahelalf thevalueofserumprogesteronelevelondayofhumanchorionicgonadotrophinadministrationmetaphaseiioocyteratioinpredictingivficsioutcomeinpatientswithnormalovarianreserve
AT bahaahaithamahmed thevalueofserumprogesteronelevelondayofhumanchorionicgonadotrophinadministrationmetaphaseiioocyteratioinpredictingivficsioutcomeinpatientswithnormalovarianreserve
AT mahranahmad valueofserumprogesteronelevelondayofhumanchorionicgonadotrophinadministrationmetaphaseiioocyteratioinpredictingivficsioutcomeinpatientswithnormalovarianreserve
AT khairymohammed valueofserumprogesteronelevelondayofhumanchorionicgonadotrophinadministrationmetaphaseiioocyteratioinpredictingivficsioutcomeinpatientswithnormalovarianreserve
AT elkhateebreham valueofserumprogesteronelevelondayofhumanchorionicgonadotrophinadministrationmetaphaseiioocyteratioinpredictingivficsioutcomeinpatientswithnormalovarianreserve
AT hegazyabdelrahman valueofserumprogesteronelevelondayofhumanchorionicgonadotrophinadministrationmetaphaseiioocyteratioinpredictingivficsioutcomeinpatientswithnormalovarianreserve
AT abdelmegedayman valueofserumprogesteronelevelondayofhumanchorionicgonadotrophinadministrationmetaphaseiioocyteratioinpredictingivficsioutcomeinpatientswithnormalovarianreserve
AT batihagaberelsaber valueofserumprogesteronelevelondayofhumanchorionicgonadotrophinadministrationmetaphaseiioocyteratioinpredictingivficsioutcomeinpatientswithnormalovarianreserve
AT alsharifkhalaff valueofserumprogesteronelevelondayofhumanchorionicgonadotrophinadministrationmetaphaseiioocyteratioinpredictingivficsioutcomeinpatientswithnormalovarianreserve
AT hettahelalf valueofserumprogesteronelevelondayofhumanchorionicgonadotrophinadministrationmetaphaseiioocyteratioinpredictingivficsioutcomeinpatientswithnormalovarianreserve
AT bahaahaithamahmed valueofserumprogesteronelevelondayofhumanchorionicgonadotrophinadministrationmetaphaseiioocyteratioinpredictingivficsioutcomeinpatientswithnormalovarianreserve